5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.51▼ | 2.54▼ | 2.54▼ | 2.72▼ | 2.46▼ |
MA10 | 2.61▼ | 2.62▼ | 2.67▼ | 2.68▼ | 2.18▲ |
MA20 | 2.73▼ | 2.76▼ | 2.77▼ | 2.52▼ | 1.86▲ |
MA50 | 2.81▼ | 2.72▼ | 2.72▼ | 2.14▲ | 1.72▲ |
MA100 | 2.69▼ | 2.53▼ | 2.44▼ | 1.84▲ | N/A |
MA200 | 2.36▲ | 2.25▲ | 2.12▲ | 1.70▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.036▼ | -0.050▼ | -0.059▼ | -0.021▼ | 0.105▲ |
RSI | 19.533▼ | 26.940▼ | 29.638▼ | 50.060▲ | 58.385▲ |
STOCH | 0.000▼ | 1.302▼ | 1.042▼ | 54.782 | 45.516 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -82.611▼ | -52.466 |
CCI | -173.631▼ | -161.310▼ | -141.693▼ | -85.645 | 118.242▲ |
Wednesday, April 24, 2024 05:00 AM
SAN ANTONIO, April 24, 2024--bioAffinity Technologies is developing diagnostics based on its proprietary platform for use with BAL fluid to detect lung cancer and to detect COPD.
|
Wednesday, April 24, 2024 03:15 AM
In a nutshell, BioAffinity Technologies Inc (BIAF) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note ...
|
Tuesday, April 23, 2024 04:00 PM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
24/04/24 | 2.52 | 2.66 | 2.38 | 2.45 | 112,523 |
23/04/24 | 2.99 | 3.10 | 2.52 | 2.59 | 402,123 |
22/04/24 | 2.77 | 3.1626 | 2.7401 | 3.00 | 244,130 |
19/04/24 | 2.81 | 2.88 | 2.73 | 2.78 | 218,778 |
18/04/24 | 2.93 | 2.9897 | 2.76 | 2.79 | 142,838 |
17/04/24 | 2.89 | 3.10 | 2.8874 | 2.91 | 209,537 |
16/04/24 | 2.80 | 2.89 | 2.50 | 2.83 | 130,196 |
15/04/24 | 2.33 | 2.89 | 2.321 | 2.76 | 443,326 |
12/04/24 | 2.48 | 2.48 | 2.31 | 2.36 | 160,052 |
11/04/24 | 2.52 | 2.55 | 2.30 | 2.35 | 184,391 |
|
|
||||
|
|
||||
|
|